Back to Treatments

Treatment

Imatinib

1
Conditions
306
Trials
20K
Participants
65%
Average Safety

Condition Evidence

Chronic myeloid leukemia

306 trials · 20K participants

90% effectiveness · 65% safety
Imatinib | DFDA